Category: Christopher Gill

US Toughens Rules for Clinical-Trial Transparency

Scientific American Christopher Gill, School of Medicine The disappointing results of clinical trials will no longer be able to languish unpublished, thanks to rules released on September 16 by the U.S. Department of Health and Human Services (HHS) and the U.S. National Institutes of Health (NIH). Expert quote: “From the perspective of consumers and science, […]

If we want medicine to be evidence-based, what should we think when the evidence doesn’t agree?

The Conversation US By Christopher Gill, School of Public Health To understand if a new treatment for an illness is really better than older treatments, doctors and researchers look to the best available evidence. Health professionals want a “last word” in evidence to settle questions about what the best modes of treatment are… View full […]

Unpredictable virus means no one can promise last year’s flu season won’t happen again

Modern Healthcare Christopher Gill, School of Public Health After last year’s devastating flu season, which hospitalized the largest number of seniors in the U.S. ever recorded, public health officials have had to assure providers that the flu vaccines they’re getting right about now will work… Expert quote: “We’re committing to which flu strains we’re going […]

Are Ultra-Orthodox Turning Away From Vaccination?

The Jewish Daily Forward Christopher Gill, School of Public Health, Center for Global Health & Development A prominent ultra-Orthodox rabbi has drawn criticism for calling vaccines a “hoax,” but his beliefs are not uncommon in Orthodox circles… Expert quote: “If a population were entirely self-contained, like living on an island with a force field around it, […]

Parents of ailing boys go over FDA

Boston Herald Christopher Gill, School of Public Health, Center for Global Health & Development Parents desperate to give their children a fighting chance against a deadly, muscle-destroying disease are doing an end run around the FDA and pleading directly with the White House to push regulators to approve a breakthrough drug that could transform the […]